Suppr超能文献

基于纳米金刚石的制剂作为淋巴瘤的免疫调节剂和潜在治疗方法。

Nanoscale Diamond-Based Formulation as an Immunomodulator and Potential Therapeutic for Lymphoma.

作者信息

Paladhi Ankush, Rej Abhinandan, Sarkar Debanjan, Singh Ranjeet, Bhattacharyya Sankar, Sarkar Prasanta Kumar, Kar Pulak Kanti, Manna Partha Pratim, Hira Sumit Kumar

机构信息

Cellular Immunology Laboratory, Department of Zoology, The University of Burdwan, Burdwan, India.

Immunobiology Lab, Department of Zoology, Sidho Kanho Birsha University, Purulia, India.

出版信息

Front Pharmacol. 2022 Apr 4;13:852065. doi: 10.3389/fphar.2022.852065. eCollection 2022.

Abstract

Integrative medicine practices, such as Ayurveda, are popular in India and many South Asian countries, yet basic research to investigate the concepts, procedures, and medical benefits of ayurvedic products has received little attention and is not fully understood. Here, we report a functional nanodiamond-based traditional Ayurvedic herbomineral formulation, (Ayu_ND), for the treatment of solid tumors called Dalton's lymphoma generated in CD1 mice. Ayu_ND-mediated immunostimulation significantly reduces tumor cell proliferation and induces apoptosis aided by the active participation of dendritic cells. Immunomodulatory Ayu_ND treatment is highly immunostimulatory and drives dendritic cells to produce TNF-α. Treatment with Ayu_ND significantly reduces the tumor volume, inhibits metastasis in distant vascularized organs, and increases the life span of tumor-bearing animals compared with untreated littermates. These events were associated with elevated serum levels of the protective cytokines IFN-γ and TNF-α and downregulated the disease, exacerbating TGF-β. Ayu_ND-mediated therapeutic success was also accompanied by the depletion of regulatory T cells and enhanced vaccine-induced T-cell immunity, guided by the restoration of the memory CD8 T-cell pool and prevention of PD-1-mediated T cell exhaustion The results provide a basis for further evaluation of ayurvedic formulations and drug efficacy in treating cancers.

摘要

诸如阿育吠陀医学等整合医学疗法在印度和许多南亚国家很受欢迎,但对阿育吠陀产品的概念、程序和医学益处进行研究的基础研究却很少受到关注,也未得到充分理解。在此,我们报告了一种基于功能化纳米金刚石的传统阿育吠陀草药矿物配方(Ayu_ND),用于治疗在CD1小鼠中产生的名为道尔顿淋巴瘤的实体瘤。Ayu_ND介导的免疫刺激显著降低肿瘤细胞增殖,并在树突状细胞的积极参与下诱导细胞凋亡。免疫调节性Ayu_ND治疗具有高度免疫刺激性,可促使树突状细胞产生肿瘤坏死因子-α(TNF-α)。与未治疗的同窝小鼠相比,Ayu_ND治疗显著减小肿瘤体积,抑制远处血管化器官中的转移,并延长荷瘤动物的寿命。这些事件与保护性细胞因子干扰素-γ(IFN-γ)和TNF-α的血清水平升高相关,并下调了加剧疾病的转化生长因子-β(TGF-β)。Ayu_ND介导的治疗成功还伴随着调节性T细胞的耗竭以及疫苗诱导的T细胞免疫增强,这是由记忆性CD8 T细胞库的恢复和对程序性死亡蛋白1(PD-1)介导的T细胞耗竭的预防所引导的。这些结果为进一步评估阿育吠陀配方和药物在治疗癌症方面的疗效提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f26/9014173/4e8a528222dc/fphar-13-852065-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验